Boston, MA 5:30 pm – 6:00 pm Registration and Dinner...

6900 Grove Road • Building 100Thorofare, NJ 08086-9447

PresortedFirst Class Mail

US PostagePAID

Permit # 906Bellmawr NJ

1.5

Interactive Dinner Symposium

Activity chAirThomas W. Samuelson, MDAttending SurgeonMinnesota Eye Consultants, P.A.Adjunct Professor of OphthalmologyUniversity of MinnesotaMinneapolis, MN

FAcultyLouis R. Pasquale, MD Assistant Professor of OphthalmologyDepartment of OphthalmologyHarvard Medical SchoolMassachusetts Eye & Ear InfirmaryBoston, MA

Inder Paul Singh, MDPresidentEye Centers of Racine and Kenosha Racine, WI

Register Online! vindicocME.com/111217b

This continuing medical education activity is provided by This activity is supported by an educational grant from Bausch + Lomb.

Sunday, November 12, 2017 New Orleans Marriott at the Convention CenterBlane Kern D-F • Lobby Level

Activity chair Thomas W. Samuelson, MDFaculty Louis R. Pasquale, MDInder Paul Singh, MD

5:30 pm – 6:00 pmRegistration and Dinner6:00 pm – 7:30 pm CME-certified Symposium

This activity is not affiliated with the official program of AAO 2017.

Medical Therapy for Glaucoma:Advances in

New Solutions

1.5

VINDICOmedical education


for a Pressing Problem


Sunday, November 12, 2017 New Orleans Marriott at the Convention Center Blane Kern D-F, Lobby LevelNew Orleans, LA

iPad® Utilizing iPads®

Medical Therapy for Glaucoma:New Solutions

Advances in



Utilizing iPads®iPad®

5:30 pm – 6:00 pm Registration and Dinner6:00 pm – 7:30 pm CME-certified Symposium

ADA compliance: In compliance with the Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

First Name ______________________________ M.I._______ Last Name _________________________________________

Preferred Mailing Address (Home/Business) ___________________________________________________________________

______________________________________________________________________________________________________

City ___________________________ State_______ Zip Code ______________ Country ____________________________

Daytime Phone _______________________________________ Evening Phone ______________________________________

Fax ____________________________ E-mail ______________________________________ Date of Birth _______________

National Provider Identifier (NPI)_______________ Medical License Number______________ Medical License State____________

(for confirmation purposes) (for confirmation purposes) (for tracking credits ONLY)

how did you hear about this meeting?(multiple selections allowed)q Advertisement q Brochure

q E-mailq Postcard

q Web siteq Word of mouth

cME Activity requestq yES, I would like to receive information regarding future

CME activities related to this therapeutic area.

Priority Code: 583 - 1 2 3

contact information:E-mail: [email protected]

Toll-free: 877-307-5225, ext. 219 or 476

Phone: 856-994-9400, ext. 219 or 476

Fax: 856-251-0278

Mail: Registration Department 6900 Grove Road Thorofare, NJ 08086-9447

OverviewGlaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have facilitated earlier glaucoma diagnosis and subsequent timely initiation of therapy, potentially reducing irreversible blindness as well as loss of quality of life. However, many patients with glaucoma remain at risk for disease progression due to inadequate control of intraocular pressure (IOP), which may be related to inadequacy of current therapy options or lack of adherence to treatment regimens that consist of multiple therapies. Therapies for glaucoma either increase outflow or decrease production of aqueous humor to reduce IOP, but IOP must be tightly controlled to provide optimal patient outcomes. In this activity, experts in the field will review and evaluate the latest clinical evidence for the safety and efficacy of current, new, and emerging classes of therapy, as well as discuss their mechanisms of action, and provide clinical insights into the effective management of IOP with presentation of patient case studies.

LearNiNG ObjecTiveSUpon successful completion of this activity, participants should be better able to:

• Assess the benefits and limitations of current options for ocular hypertension and primary open-angle glaucoma.

• Investigate emerging therapies that offer a unique mechanism of action for the treatment of glaucoma.

• Review new clinical evidence pertaining to safety and efficacy of the latest conventional agents and investigational therapeutics for the treatment of glaucoma.

TarGeT audieNceThe intended audience for this activity is ophthalmologists and other health care professionals involved in the treatment of patients with glaucoma.

1.5

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

iPad® is a trademark of Apple Inc., registered in the U.S. and other countries.

aGeNda5:30 pm – 6:00 pm Registration and Dinner

6:00 pm – 6:10 pm Introduction and Pretest Thomas W. Samuelson, MD

6:10 pm – 6:30 pm Targeting IOP through Therapies with New Mechanisms of Action Louis R. Pasquale, MD

6:30 pm – 6:45 pm Treating Glaucoma with an Eye on Expanding Options Inder Paul Singh, MD

6:45 pm – 7:15 pm Case Presentations Thomas W. Samuelson, MD

7:15 pm – 7:20 pm Posttest

7:20 pm – 7:30 pm Question and Answer



Sunday, November 12, 2017 New Orleans Marriott at the Convention CenterBlane Kern D-F, Lobby LevelNew Orleans, LA




New Solutions for a Pressing Problem


© 2

017

iSto

ckph

oto.

com

/ass

29; B

rani

mir7

6

Specialty (select one)q Retina / Vitreousq Glaucomaq Cataract Surgeryq Refractive Surgery

Degree (please specify)q MD/DOq PhDq OD q PharmD/RPh

q PAq RN/BSN/MSNq NPq Industry

q Other:_______ q Cornea / External diseaseq General Ophthalmologyq Other:_____________



US PostagePAID


1.5












New Solutions

1.5








Advances in





ADA compliance: In compliance with the Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests.

First Name ______________________________ M.I._______ Last Name _________________________________________

Preferred Mailing Address (Home/Business) ___________________________________________________________________

______________________________________________________________________________________________________

City ___________________________ State_______ Zip Code ______________ Country ____________________________

Daytime Phone _______________________________________ Evening Phone ______________________________________

Fax ____________________________ E-mail ______________________________________ Date of Birth _______________

National Provider Identifier (NPI)_______________ Medical License Number______________ Medical License State____________

(for confirmation purposes) (for confirmation purposes) (for tracking credits ONLY)

how did you hear about this meeting?(multiple selections allowed)q Advertisement q Brochure

q E-mailq Postcard

q Web siteq Word of mouth

cME Activity requestq yES, I would like to receive information regarding future

CME activities related to this therapeutic area.

Priority Code: 583 - 1 2 3

contact information:E-mail: [email protected]

Toll-free: 877-307-5225, ext. 219 or 476

Phone: 856-994-9400, ext. 219 or 476

Fax: 856-251-0278

Mail: Registration Department 6900 Grove Road Thorofare, NJ 08086-9447

OverviewGlaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have facilitated earlier glaucoma diagnosis and subsequent timely initiation of therapy, potentially reducing irreversible blindness as well as loss of quality of life. However, many patients with glaucoma remain at risk for disease progression due to inadequate control of intraocular pressure (IOP), which may be related to inadequacy of current therapy options or lack of adherence to treatment regimens that consist of multiple therapies. Therapies for glaucoma either increase outflow or decrease production of aqueous humor to reduce IOP, but IOP must be tightly controlled to provide optimal patient outcomes. In this activity, experts in the field will review and evaluate the latest clinical evidence for the safety and efficacy of current, new, and emerging classes of therapy, as well as discuss their mechanisms of action, and provide clinical insights into the effective management of IOP with presentation of patient case studies.

LearNiNG ObjecTiveSUpon successful completion of this activity, participants should be better able to:

• Assess the benefits and limitations of current options for ocular hypertension and primary open-angle glaucoma.

• Investigate emerging therapies that offer a unique mechanism of action for the treatment of glaucoma.

• Review new clinical evidence pertaining to safety and efficacy of the latest conventional agents and investigational therapeutics for the treatment of glaucoma.

TarGeT audieNceThe intended audience for this activity is ophthalmologists and other health care professionals involved in the treatment of patients with glaucoma.

1.5

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

iPad® is a trademark of Apple Inc., registered in the U.S. and other countries.

aGeNda5:30 pm – 6:00 pm Registration and Dinner

6:00 pm – 6:10 pm Introduction and Pretest Thomas W. Samuelson, MD

6:10 pm – 6:30 pm Targeting IOP through Therapies with New Mechanisms of Action Louis R. Pasquale, MD

6:30 pm – 6:45 pm Treating Glaucoma with an Eye on Expanding Options Inder Paul Singh, MD

6:45 pm – 7:15 pm Case Presentations Thomas W. Samuelson, MD

7:15 pm – 7:20 pm Posttest

7:20 pm – 7:30 pm Question and Answer



Sunday, November 12, 2017 New Orleans Marriott at the Convention CenterBlane Kern D-F, Lobby LevelNew Orleans, LA




New Solutions for a Pressing Problem


© 2

017

iSto

ckph

oto.

com

/ass

29; B

rani

mir7

6

Specialty (select one)q Retina / Vitreousq Glaucomaq Cataract Surgeryq Refractive Surgery

Degree (please specify)q MD/DOq PhDq OD q PharmD/RPh

q PAq RN/BSN/MSNq NPq Industry

q Other:_______ q Cornea / External diseaseq General Ophthalmologyq Other:_____________



US PostagePAID


1.5












New Solutions

1.5








Advances in





Boston, MA 5:30 pm – 6:00 pm Registration and Dinner...

Documents

Transcript of Boston, MA 5:30 pm – 6:00 pm Registration and Dinner...